Literature DB >> 17338672

Preeclampsia and future cardiovascular risk.

J Newstead1, P von Dadelszen, Laura A Magee.   

Abstract

Pregnancy is a metabolic and vascular 'stress test' for women and those who 'fail' are at increased risk of long-term cardiovascular complications. Specifically, women who develop preeclampsia (and/or other manifestations of placental dysfunction) are at increased risk of coronary heart disease, stroke and cardiovascular disease in general. The risk is highest among women who develop both maternal (e.g., hypertension and proteinuria) and fetal (e.g., intrauterine growth restriction) manifestations of abnormal placentation, especially with preterm delivery. Most women who develop a maternal placental syndrome return to a normal clinical state in the weeks following pregnancy and their absolute risk of cardiovascular disease in the short term is very low. However, perhaps having a placentally complicated pregnancy affords women the opportunity to personalize risk and take action. Action is needed. The fact that we, as a population, are getting heavier and more sedentary is an urgent public health issue. The American Heart Association recommends that all women (even those at low cardiovascular risk) pursue dietary and lifestyle changes, in addition to smoking cessation. Engaging women of child-bearing age who may be motivated by a complicated pregnancy would be very valuable, from a public health perspective, given the prevalence and importance of cardiovascular disease in women, and the central role of the woman as caregiver to children, spouses and other family members.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17338672     DOI: 10.1586/14779072.5.2.283

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  21 in total

1.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

Review 2.  Protein nitration in placenta - functional significance.

Authors:  R P Webster; V H J Roberts; L Myatt
Journal:  Placenta       Date:  2008-10-11       Impact factor: 3.481

3.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13

Review 4.  Gene expression in the placenta: maternal stress and epigenetic responses.

Authors:  Ciprian P Gheorghe; Ravi Goyal; Ashwani Mittal; Lawrence D Longo
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

5.  A prospective study of maternal carboxyhaemoglobin and pre-eclampsia risk.

Authors:  Carole B Rudra; Michelle A Williams; Melissa A Schiff; Jane Q Koenig; Russell Dills; Jianbo Yu
Journal:  Paediatr Perinat Epidemiol       Date:  2010-01       Impact factor: 3.980

Review 6.  The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

Authors:  Kirk P Conrad; John M Davison
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19

Review 7.  Combined Oral Contraceptive Pill-Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities.

Authors:  Madugodaralalage D S K Gunaratne; Bjorg Thorsteinsdottir; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2021-05-13       Impact factor: 5.369

8.  Ambient carbon monoxide and fine particulate matter in relation to preeclampsia and preterm delivery in western Washington State.

Authors:  Carole B Rudra; Michelle A Williams; Lianne Sheppard; Jane Q Koenig; Melissa A Schiff
Journal:  Environ Health Perspect       Date:  2011-01-24       Impact factor: 9.031

9.  Risk of pre-eclampsia in patients with a maternal genetic predisposition to common medical conditions: a case-control study.

Authors:  K J Gray; V P Kovacheva; H Mirzakhani; A C Bjonnes; B Almoguera; M L Wilson; S A Ingles; C J Lockwood; H Hakonarson; T F McElrath; J C Murray; E R Norwitz; S A Karumanchi; B T Bateman; B J Keating; R Saxena
Journal:  BJOG       Date:  2020-09-14       Impact factor: 6.531

10.  PPAR Action in Human Placental Development and Pregnancy and Its Complications.

Authors:  Fritz Wieser; Leslie Waite; Christophe Depoix; Robert N Taylor
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.